Home
Metropolis Healthcare Ltd Share Price History
Metropolis Healthcare Ltd
NSE : 25 Apr, 2025
1740.2-24.7 (-1.4%)
Prev Close
1764.9
Open Price
1765.2
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
80430
Today's High / Low
1768.3 / 1726.0
52 WK High / Low
2318.3 / 1315.0
Market Price of Metropolis Healthcare Ltd
1M
1Y
3Y
5Y
Monitoring Metropolis Healthcare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 112.38 |
| YoY Gr. | - |
| Net Profit (Cr.) | 107 |
| BVPS | 338.61 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 29.32 |
| Op. Profit Mgn % | 27.17 |
| Net Profit Mgn % | 14.92 |
| Debt to Equity % | 0.05 |
Latest Shareholding
Promoters Holdings Over Time
About Metropolis Healthcare Ltd
- Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners.
- The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards.
- In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah.
- Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis.
- On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr.
Popular Search
FAQs for Metropolis Healthcare Ltd Share Price History
What are the key events that typically impact Metropolis Healthcare Ltd's share price history?
Key events that impact Metropolis Healthcare Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Metropolis Healthcare Ltd's share price history?
Stock splits reduce the nominal price of Metropolis Healthcare Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Metropolis Healthcare Ltd?
Dividends can influence Metropolis Healthcare Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Metropolis Healthcare Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Metropolis Healthcare Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Metropolis Healthcare Ltd’s share price history?
To understand Metropolis Healthcare Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
